INTAS Develops COVID-19 Hyperimmune Globulin - A New Treatment | Exclusive News

INTAS Develops COVID-19 Hyperimmune Globulin – A New Treatment

By editor3 on August 27, 2020August 27, 2020

Continue reading

Live Updates COVID-19 CASES

World 113,100,697

World

Confirmed: 113,100,697

Active: 21,878,345

Recovered: 88,713,439

Death: 2,508,913
USA 28,974,623

USA

Confirmed: 28,974,623

Active: 9,115,931

Recovered: 19,340,329

Death: 518,363
India 11,046,914

India

Confirmed: 11,046,914

Active: 151,671

Recovered: 10,738,501

Death: 156,742
Brazil 10,326,008

Brazil

Confirmed: 10,326,008

Active: 794,911

Recovered: 9,281,018

Death: 250,079
France 3,661,410

France

Confirmed: 3,661,410

Active: 3,322,639

Recovered: 253,450

Death: 85,321
Italy 2,848,564

Italy

Confirmed: 2,848,564

Active: 389,433

Recovered: 2,362,465

Death: 96,666
Germany 2,416,037

Germany

Confirmed: 2,416,037

Active: 128,727

Recovered: 2,217,700

Death: 69,610
Pakistan 575,941

Pakistan

Confirmed: 575,941

Active: 23,281

Recovered: 539,888

Death: 12,772
Bangladesh 544,544

Bangladesh

Confirmed: 544,544

Active: 42,367

Recovered: 493,798

Death: 8,379
China 89,871

China

Confirmed: 89,871

Active: 281

Recovered: 84,954

Death: 4,636
Sri Lanka 81,467

Sri Lanka

Confirmed: 81,467

Active: 4,496

Recovered: 76,514

Death: 457
Afghanistan 55,680

Afghanistan

Confirmed: 55,680

Active: 4,156

Recovered: 49,086

Death: 2,438